Alisertib

Generic Name: Alisertib

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₇H_₂₀ClFN_₄O_₄

CAS Number: 1028486-01-2

Unique Ingredient Identifier: T66ES73M18

Background: Alisertib is a novel aurora A kinase inhibitor under investigation for the treatment of various forms of cancer.

Indication: For the treatment of various forms of cancer.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results

Puma Biotechnology will host a conference call on Nov 7, 2024, at 1:30 p.m. PST/4:30 p.m. EST following Q3 2024 financial results release. The call will be accessible via phone or webcast on their website, with a replay available for 90 days.

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy